Φορτώνει......
Nanomedicine in coronary artery disease
Nanomedicine is one of the most promising therapeutic modalities researchers are working on. It involves development of drugs and devices that work at the nanoscale (10–9 m). Coronary artery disease (CAD) is responsible for more than a third of all deaths in age group >35 years. With such a huge...
Αποθηκεύτηκε σε:
| Τόπος έκδοσης: | Indian Heart J |
|---|---|
| Κύριοι συγγραφείς: | , , , , , , |
| Μορφή: | Artigo |
| Γλώσσα: | Inglês |
| Έκδοση: |
Elsevier
2017
|
| Θέματα: | |
| Διαθέσιμο Online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5414944/ https://ncbi.nlm.nih.gov/pubmed/28460774 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ihj.2017.02.007 |
| Ετικέτες: |
Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!
|